Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2014-09-26FDA Approved: CARVEDILOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for carvedilol submitted by Glenmark Pharmaceuticals USA, resulting in changes to the drug’s lab…
-
FDA approval · 2014-09-26FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for RAMIPRIL from Hikma Pharmaceuticals USA Inc. under ANDA077900.
-
FDA approval · 2014-09-26FDA Approved: RAMIPRIL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for RAMIPRIL (ramipril) from Zydus Lifesciences Limited.
-
FDA approval · 2014-09-26FDA Approved: QUINAPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Quinapril hydrochloride by Aurobindo Pharma Limited.
-
FDA approval · 2014-09-25FDA Approved: QUINAPRIL — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Quinapril from Chartwell RX, LLC, authorizing a generic quinapril product under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Combined Transvenous and Epicardial Lead Placement Procedure for Implantation of Cardiac Resynchronization Devices: a Feasibility Study. [NA]
Feasibility study exploring a combined transvenous and epicardial lead placement technique for implanting cardiac resynchronization therapy …
-
FDA approval · 2014-09-25FDA Approved: CARVEDILOL — Supplemental Application (Advagen Pharma Ltd)
The FDA approved Advagen Pharma Ltd's supplemental application for carvedilol (generic). This is an approval of a supplemental filing for a …
-
FDA approval · 2014-09-24FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for a generic spironolactone and hydrochlorothiazide combination product from Sun Pharmaceutical Ind…
-
FDA approval · 2014-09-22FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for carvedilol by Aurobindo Pharma Limited. This represents approval of a generic carvedilol pro…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Preliminary Study Examining Heart Failure Patients Responses to Depression Education [NA]
This trial update notes the termination of a Duke University–sponsored study evaluating how heart failure patients respond to depression edu…
-
FDA approval · 2014-09-21FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for carvedilol from Aurobindo Pharma Limited, confirming a generic version under ANDA078332.
-
FDA approval · 2014-09-19FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for Losartan Potassium (generic), granting a supplemental approval for the prod…
-
CLINICAL_TRIALS research · 2014-09-19Clinical Trial Update: Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease
Clinical trial update examining the relationship between heart rate and prognosis across multiple cardiovascular conditions in people with s…
-
FDA approval · 2014-09-18FDA Approved: HYDRALAZINE — Original Application (Nivagen Pharmaceuticals, Inc.)
FDA approved the original generic application for hydralazine hydrochloride tablets from Nivagen Pharmaceuticals, Inc., for the treatment of…
-
FDA approval · 2014-09-17FDA Approved: CARVEDILOL — Supplemental Application (UNICHEM PHARMACEUTICALS (USA), INC.)
The FDA approved a supplemental application for carvedilol, submitted by Unichem Pharmaceuticals (USA), Inc. Carvedilol is a beta-blocker us…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Heart at Home- a Self-care Study [NA]
This entry notes the completion of a clinical trial evaluating a self-care program for heart failure, with results posted in September 2014.
-
CLINICAL_TRIALS withdrawal · 2014-09-17Clinical Trial Update: Heart Failure and Regional Specific Exercise Training Stimulus [NA]
The clinical trial NCT02077426 evaluating region-specific exercise training for heart failure has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Improving Clinician Communication Skills (ICCS) [Phase 3]
Phase 3 trial evaluating a program to improve clinician communication skills has completed. The ICCS study is sponsored by the University of…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Resistance Exercise Program and Branched Chain Amino Acid Supplementation in Heart Failure Patients [NA]
A completed clinical trial evaluated a resistance exercise program with branched-chain amino acid supplementation in heart failure patients.
-
CLINICAL_TRIALS safety_alert · 2014-09-11Clinical Trial Update: The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia
This clinical trial update notes potential risks of heart failure and pneumonia with pramipexole and other dopamine agonists.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels
Completed clinical trial exploring phenotypes of patients with elevated aldosterone in acute heart failure.
-
CLINICAL_TRIALS withdrawal · 2014-09-09Clinical Trial Update: Study to Determine the Safety and Feasibility of Utilizing the CD Leycom Pressure/Conductance Catheter to Determine Optimal LV Pacing Site [Phase 1]
A Phase 1 study to assess the safety and feasibility of using the CD Leycom Pressure/Conductance Catheter to determine the optimal left vent…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy [NA]
This clinical trial update notes the completion of a study comparing empiric versus imaging-guided left ventricular lead placement in cardia…
-
FDA approval · 2014-09-04FDA Approved: TRANDOLAPRIL — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for Trandolapril tablets from Epic Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: ADHESION TO THERAPEUTIC STRATEGIES FOR OUTPATIENTS WITH HEART FAILURE - ADhesion-HF [NA]
The ADhesion-HF trial evaluating adhesion-based therapeutic strategies for outpatients with heart failure has completed, according to Clinic…